L'AMQ dans le British Medical Journal (BMJ)
Le BMJ mentionnait l'Association médicale du Québec dans son éditorial du 4 décembre 2013 dont le titre était : "Too Much Medicine: from evidence to action"
Extraits de l’éditorial (en anglais seulement)
BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f7141 (Published 4 December 2013)
By Ray Moynihan, senior research fellow1, Carl Heneghan, professor of evidence based medicine2, Fiona Godlee, editor in chief3
- Centre for Research in Evidence-Based Practice, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD 4229, Australia
- Centre for Evidence-Based Medicine, University of Oxford, Oxford UK
- BMJ, London, UK
Abstract submission open for 2014 Preventing Overdiagnosis conference
Well known for their debates about independence, the people of Quebec may soon attract global attention for their campaign to wind back the harms of too much medicine. Earlier this year, the Quebec Medical Association issued a position paper on overdiagnosis and overtreatment and created a working party to identify causes and develop solutions. In September, a delegation of the most influential people within Quebec’s health system —representatives of doctors, nurses, pharmacists, and hospital managers— attended the inaugural Preventing Overdiagnosis conference in Dartmouth, New Hampshire, United States. Now they’re busy building a knowledge base within the Canadian province around strategies to counter overdiagnosis and overtreatment. In Quebec, evidence is informing action. […]
This current move to expose and combat the problem of medical excess is being driven in part by researchers steeped in the evidence informed approach to medicine. Bond University’s Centre for Research in Evidence-Based Practice has helped initiate this series of international scientific conferences, and now the University of Oxford’s Centre for Evidence Based Medicine will host the second of them. This underscores the fact that evidence is not produced and used in a value-free vacuum. Rather, it is generated, disseminated, and sometimes distorted by vested interests – both professional and commercial. For example, "evidence based" guidelines may sometimes contribute to overdiagnosis or overtreatment through the quality measures that enforce them, or through expanded disease definitions produced by heavily conflicted guideline panels. As attempts to wind back unnecessary medical excess intensify, some of those vested interests will no doubt fight back hard to defend their turf and their markets. And that’s another reason that we look forward to hearing how the people from Quebec are doing, when they report back on their local actions at the conference in Oxford next year.
Cite this as: BMJ 2013;347:f7141